Salt-sensitive hypertension: Renal and cardiovascular implications

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 9, Issue 3, 1999, Pages 143-156

  Campese, V M ^a  

^a LAC USC MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR SYSTEM; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; GENETICS; GLOMERULUS FILTRATION RATE; HEMODYNAMICS; HUMAN; HYPERTENSION; KIDNEY; METABOLISM; PATHOPHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; RISK FACTOR; SALT INTAKE; VASCULAR ENDOTHELIUM;

CARDIOVASCULAR SYSTEM; ENDOTHELIUM, VASCULAR; GLOMERULAR FILTRATION RATE; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION; KIDNEY; RENIN-ANGIOTENSIN SYSTEM; RISK FACTORS; SODIUM CHLORIDE, DIETARY;

EID: 0033144957     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (147)

1. Taubes G (1998) The (political) science of salt. Science 281:898-907
2. INTERSALT Cooperative Research Group (1988) INTERSALT: An intentional study of electrolyte excretion and blood pressure: Results for 24 hour urinary sodium and potassium excretion. Br Med J 297: 319-328
3. Khaw KT, Barrett-Connor E (1988) The association between blood pressure, age, and dietary sodium and potassium: a population study. Circulation 77: 53-61
4. MacGregor GA, Markandu ND, Sagnella GA, Singer DRJ, Cappuccio FP (1989) Double-blind study of three sodium intakes and long-term effects of sodium restriction in essential hypertension. Lancet ii: 1244-1247
5. Grobbee DE, Hoffman A (1986) Does sodium restriction lower blood pressure? Br Med J 293: 27-29
6. Egan BM, Weder AB, Petrin J, Hoffman G (1991) Neurohumoral and metabolic effects of short-term dietary NACl restriction in men. Am J Hypertens 4: 416-421
7. Kawasaki T, Delea CS, Bartter FC, Smith H (1978) The effect of high sodium and low-sodium intakes on blood pressure and other related variables in human subjects with idiopathic hypertension. Am J Med 64: 193-198
8. Campese VM, Romoff MS, Levitan D, Saglikes Y, Friedler RM, Massry SG (1982) Abnormal relationship between Na intake and sympathetic nervous system activity in salt-sensitive patients with essential hypertension. Kidney Int 21: 371-378
9. Weinberger MH, Miller JZ, Luft FC, Grim CE, Fineberg NS (1986) Definitions and characteristics of sodium sensitivity and blood pressure resistance. Hypertension 8 (Suppl II): II 127-II 134
10. Luft FC, Miller JZ, Grím CE, Fineberg NS, Christian JC, Daugherty SA, Weinberger MH (1991) Salt-sensitivity and resistance of blood pressure. Age and race as factors in physiological responses. Hypertension 17 (Suppl I): I102-I108
11. Tuck ML (1991) Role of salt in the control of blood pressure in obesity and diabetes mellitus. Hypertension 17(Suppl I): I-135-I-142
12. Weidmann P, Ferrari P (1991) Central role of sodium in hypertension in diabetic subjects. Diabetes Care 14: 220-232
13. Barba G, Cappuccio FP, Russo L, Stinga F, Iacone R, Strazzullo P (1996) Renal function and blood pressure response to dietary salt restriction in normotensive men. Hypertension 27: 1160-1164.
14. Sullivan JM, Prewitt RL, Ratts TE (1988) Sodium sensitivity in normotensive and borderline hypertensive humans. Am J Med 295: 370-377
15. Widgren BR, Herlitz H, Hedner T, Berglund G, Wikstrand J, Jonsson O, Andersson OK (1991) Blunted renal sodium excretion during acute saline loading in normotensive men with positive family histories of hypertension. Am J Hypertens 4: 570-578
16. Luft FC, Fineberg NS, Weinberger MH (1992) The influence of age on renal function and renin and aldosterone responses to sodium-volume expansion and contraction in normotensive and mildly hypertensive humans. Am J Hypertens 5: 520-528
17. + sensitivity and blood pressure resistance. Hypertension 8: II 127-II 134
18. Grim CE, Henry JP, Myers H (1995) High blood pressure in blacks: salt, slavery, survival, stress, and racism. In: Laragh JH, Brenner BM (Eds) Hypertension: pathophysiology, diagnosis, and management, ed 2. Raven Press, New York, pp. 171-207
19. Sharma AM, Schattenfroh S, Kribben A, Distler A (1989) Reliability of salt sensitivity testing in normotensive subjects. Clin Wochenschr 67: 632-634
20. Weinberger MH, Fineberg NS (1991) Sodium and volume sensitivity on blood pressure: age and pressure changes over time. Hypertension 12: 67-71
21. Guyton AC, Langston JB, Navar G (1964) Theory for renal autoregulation by feedback at the juxtaglomerular apparatus. Circ Res 14/15 (Suppl): I-187-I-197
22. Campese VM (1988) Effects of calcium antagonists on deranged modulation of the renal function curve in salt-sensitive patients with essential hypertension. Am J Cardiol 62:85G-91G
23. Kimura G, Ashida T, Abe H, Kawano Y, Yoshimi H, Sanai T, Imanishi M, Yoshida K, Kawamura M, Kojima S, Kuramochí M, Omae T (1990) Sodium sensitive and sodium retaining hypertension. Am J Hypertens 3: 854-858
24. Kimura G, Brenner BM (1993) Method for distinguishing salt-sensitive from non-salt-sensitive forms of human and experimental hypertension. Curr Opin Nephrol Hypertens 2: 341-349
25. Campese VM, Parise M, Karubian F, Bigazzi R (1991) Abnormal renal hemodynamics in black salt-sensitive patients with hypertension. Hypertension 18: 805-812
26. Bigazzi R, Bianchi S, Baldari D, Sgherri G, Baldari G, Campese VM (1994) Microalbuminuria in salt-sensitive patients. A marker for renal and cardiovascular risk factors. Hypertension 23: 195-199
27. Parmer RJ, Stone RA, Cervenka JH (1994) Renal hemodynamics in essential hypertension. Racial differences in response to changes in dietary sodium. Hypertension 24: 752-757
28. Campese VM (1996) Why is salt-sensitive hypertension so common in blacks? Hypothesis. Nephrol Dial Transplant 12: 399-403
29. Kimura G, Saito F, Kojima S, Yoshimi H, Abe H, Kawano Y, Yoshida K, Ashida T, Kawamura M, Kuramochi M, Ito K, Omae T (1987) Renal function curve in patients with secondary forms of hypertension. Hypertension 10: 11-15
30. Gill JR, Gullner HG, Lake R, Lakatua DJ, Lan G (1988) Plasma and urinary catecholamines in salt-sensitive idiopathic hypertension. Hypertension 11: 312-319
31. Romoff MS, Keusch G, Campese VM, Wang WS, Friedler RM, Weidmann P, Massry SG (1978) Effect of sodium intake on plasma catecholamines in normal subjects. J Clin Endocrinol Metab 48: 26-31
32. Lawton WJ, Sinkey CA, Fitz AE, Mark AL (1988) Dietary salt produces abnormal renal vasoconstrictor responses to upright posture in borderline hypertensive subjects. Hypertension 11: 529-536
33. Chen YF, Meng Q, Wyss JM, Jin H, Oparil S (1988) High NaCl diet reduces hypothalamic norepinephrine turnover in hypertensive rats. Hypertension 11: 55-62
34. Koepke JP, Jones S, DiBona GF (1988) High sodium intake increases sensitivity of central alpha-2 adrenoceptors in spontaneously hypertensive rats. Hypertension 11: 326-333
35. Pecker MS, James GD, Laragh JH, Sealey JE (1993) Plasma prorenin is inversely related to salt sensitivity in borderline to mild hypertension. J Am Soc Nephrol 4: 537A
36. Hall JE, Guyton AC, Smith MJ Jr, Coleman TG (1980) Blood pressure and renal function during chronic changes in sodium intake: Role of angiotensin. Am J Physiol 239: F271-F280
37. Kimura G, Uzu T, Nakamura S, Inenaga T, Fujii T (1996) High sodium sensitivity and glomerular hypertension/hyperfiltration in primary aldosteronism. J Hypertens 14: 1463-1468
38. Ferranini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, Bevilacqua S (1987) Insulin resistance in essential hypertension. N Engl J Med 317: 350-357
39. DeFronzo, RA, Cooke CR, Andres R, Faloona GR, David PJ (1975) The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man. J Clin Invest 55: 845-855
40. Lansberg L, Young JB (1985) Insulin-mediated glucose metabolism in the relationship between dietary intake and sympathetic nervous system activity. Int J Obes 9: 63-68
41. Jamerson KA, Julius S, Gudbrandsson T, Andersson O, Brant DO (1993) Reflex sympathetic activation induces acute insulin resistance in the human forearm. Hypertension 21: 618-623
42. Rocchini AP, Key J, Bondie D, Chico R, Moorehead C, Katch V, Martin M (1989) The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents. N Engl J Med 321: 580-585
43. Sharma AM, Schorr U, Distler A (1993) Insulin resistance in young salt-sensitive normotensive subjects. Hypertension 21: 273-279
44. Zavaroni I, Coruzzi P, Bonini L, Mossini GL, Musiari L, Gasparini P, Fantuzzi H, Reaven GM (1995) Association between salt sensitivity and insulin concentrations in patients with hypertension. Am J Hypertens 8: 855-858
45. Galletti F, Strazzullo P, Ferrara I, Annuzzi G, Rivellese AA, Gatto S, Mancini M (1997) NaCl sensitivity of essential hypertensive patients is related to insulin resistance. J Hypertens 15: 1485-1491
46. 2+ exchange/ hypertension hypothesis. Am J Med 77: 45-57
47. Manunta P, Rogowski AC, Hamilton BP, Hamlyn JM (1994) Ouabain-induced hypertension in the rat: relationships among circulating and tissue ouabain and blood pressure. J Hypertens 12: 549-560
48. Doris PA, Jenkins LA, Stocco DM (1994) Is ouabain an authentic endogenous mammalian substance derived from the adrenal? Hypertension 23: 632-638
49. Hamlyn JM, Manunta P (1992) Ouabain, digitalis-like factors and hypertension. J Hypertens 10 (Suppl 7): S99-S 111
50. + ATPase of Nigerians. Afr J Med Sci 20: 75-82
51. +-Adenosine Triphosphatase. J Clin Invest 75: 1813-1820
52. Hopp L, Lasker N, Grossman S, Bamforth R, Aviv A (1986) [3H]Ouabain binding of red blood cells in whites and blacks. Hypertension 8: 1050-1057
53. Bianchi G, Tripodi G, Casari S, Salardi S, Barber BR, Garcia R, Leoni P, Torielli L, Cusi D, Ferrandi M, Pinna LA, Baralle FE, Ferrari P (1994) Two point mutations within the adducin genes are involved in blood pressure variations. Proc Natl Acad Sci 91: 3999-4003
54. Tripodi G, Valtorta F, Torielli L, Chieregatti E, Salardi S, Trusolino L, Menegon A, Ferrari P, Marchisio PC, Bianchi G (1996) Hypertension associated point mutation in the adducin α and β subunits affect actin cytoskeleton and ion transport. J Clin Invest 97: 2815-2822
55. +-ATPase in platelets of salt-sensitive hypertensive patients. J Am Soc Nephrol 6: 619A
56. +-ATPase inhibition. J Biol Chem 268: 8851-8854
57. Pressley TA (1988) Ion concentration dependent regulation of Na -K-pump abundance. J Membr Biol 105: 187-195
58. Schmouder RL, Weder AB (1989) Platelet sodium-proton exchange is increased in essential hypertension. J Hypertens 7: 325-330
59. + antiport activity in skin fibroblasts from blacks and whites. Hypertension 15: 140-145
60. Oshima T, Matsuura H, Kido K, Kajiyama G (1988) Role of cellular calcium in salt sensitivity of patients with essential hypertension. Hypertension 11: 703-707
61. Alexiewicz JM, Gaciong Z, Parise M, Karubian F, Massry SG, Campese VM (1992) Effect of dietary sodium intake on intracellular calcium in lymphocytes of salt-sensitive hypertensive patients. Am J Hypertens 5: 536-541
62. Matsuura H, Shingu T, Inoue I, Kajiyama G, Kusaka M, Matsumoto K, Kido K (1991) Significance of intracellular cations and calcium-regulating hormones on salt-sensitivity in patients with essential hypertension. Contrib Nephrol 90: 11-18
63. de Wardener, HE, MacGregor GA (1980) Dahl's hypothesis that a saluretic substance may be responsible for a sustained rise in arterial pressure: its possible role in essential hypertension. Kidney Int 18: 1-9
64. Vincenzi FF, Morris CD, Kinsel LB, Kenny M, McCarron DA (1986) Decreased calcium pump adenosine triphosphatase in red blood cells of hypertensive subjects. Hypertension 8: 1058-1066
65. Lindner A, Kenny M, Meacham AJ (1987) Effects of a circulating factor in patients with essential hypertension on intracellular free calcium in normal platelets. N Engl J Med 316: 509-513
66. 2+ transport in human neutrophils. Atherosclerosis 69: 185-190
67. Hollister AS, Menshikov M, Devyatova O (1992) Humoral factor, intraplatelet calcium, and hypertension. Am J Hypertens 5: 131S-134S
68. Kurtz TW, Morris RC (1990) Sodium-calcium interactions and salt-sensitive hypertension. Am J Hypertens 3: 152S-155S
69. Mc Carron DA (1985) Is calcium more important than sodium in the pathogenesis of hypertension? Hypertension 7: 607-627
70. 2+ prevents NaCl-induced exacerbation of hypertension and increases hypothalamic norepinephrine turnover in spontaneously hypertensive rats. J Hypertens 7: 711-719
71. Campese VM, Tawadrous M, Bianchi S (1995) Reduced renal PGE-2 excretion in salt-sensitive patients with essential hypertension. J Am Soc Nephrol 6: 753A
72. Krishna GG, Danovitch GM, Beck FWJ, Sowers JR (1985) Dopaminergic mediation of the natriuretic response to volume expansion. J Lab Clin Med 105: 214-218
73. Gill JR, Grossman E, Goldstein DS (1991) High urinary dopa and low urinary dopamine-to-dopa ratio in salt-sensitive hypertension. Hypertension 18: 614-621
74. Campese VM, Tawadrous M, Chervu I, Goldstein D (1994) Urinary catecholamines in black salt-sensitive patients with essential hypertension. J Am Soc Nephrol 5: 558A
75. Lechi A, Covi G, Lechi C, Corgnati A, Arosio E, Zatti M, Scuro LA (1978) Urinary kallikrein excretion and plasma renin activity in patients with essential hypertension and primary aldosteronism. Clin Sci Mol Med 55: 51-55
76. Favre L, Jornot L, Riondel A, Vallotton M (1985) Urinary excretion of renal prostaglandins, kallikrein, vasopressin and aldosterone in essential hypertension. Clin Exp Hypertens 7: 1663-1679
77. Hilme E, Herhtz H, Gyzander E, Hansson L (1920) Urinary kallikrein excretion is low in malignant essential hypertension. J Hypertens 10: 869-874
78. Levy SB, Talner LB, Coel MN, Holle R, Stone RA (1978) Renal vasculature in essential hypertension: racial differences. Ann Intern Med 88: 12-16
79. Zinner SH, Margolius HS, Rosner B, Keiser HR, Kass EH (1976) Familial aggregation of urinary kallikrein concentration in childhood: relation to blood pressure, race and urinary electrolytes. J Epidemiol 104: 124-132
80. Holland OB, Chud JM, Braunstein H (1980) Urinary kallikrein excretion in essential and mineralocorticoid hypertension. J Clin Invest 65: 347-356
81. Nakaoka H, Kitahara Y, Amano M, Imataka K, Fujii J, Ishibashi M, Yamaji T (1987) Effect of β-adrenoreceptor blockade on atrial natriuretic peptide in essential hypertension. Hypertension 10: 221-225
82. Montorsi P, Tonolo G, Polonia J, Hepburn D, Richards M (1987) Correlates of plasma atrial natriuretic factor in health and hypertension. Hypertension 10: 570-576
83. Sagnella GA, Markandu ND, Buckley MG, Miller MA, Singer DRJ, Cappuccio FP, MacGregor GA (1991) Atrial natriuretic peptides in essential hypertension: basal plasma levels and relationship to sodium balance. Can J Physiol Pharmacol 69: 1592-1600
84. Nimura S (1991) Attenuated release of atrial natriuretic factor due to sodium loading in salt-sensitive essential hypertension. Jpn Heart J 32: 167-178
85. Campese VM, Tawadrous M, Bigazzi R, Bianchi S, Mann AS, Oparil S, Raij L (1996) Salt intake and plasma atrial natriuretic peptide and nitric oxide in hypertension. Hypertension 28: 335-340
86. John SWM, Krege JH, Oliver PM, Hagaman JR, Hodgin JB, Pang SC, Flynn TG, Smithies O (1995) Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science 267: 679-681
87. Lopez MJ, Wong SKF, Kishimoto I, Dubois S, Mach V, Friesen J, Garbers DL, Bluve A (1995) Salt-resistant hypertension in mice lacking guanylyl cyclase-A receptor for atrial natriuretic peptide. Nature 378: 65-68
88. Ogawa Y, Itoh H, Tamura N, Suga SI, Yoshimata T, Vehira H, Matsuga S, Shiono S, Nishimoto H, Nakao K(1994) Molecular cloning of the complementary DNA and gene that encodes mouse brain natriuretic peptide and generation of transgenic mice that overexpress the brain natriuretic peptide gene. J Clin Invest 93: 1911-1921
89. Steinhelper ME, Cochrane KL, Field IJ (1990) Hypotension in transgenic mice expressing atrial natriuretic factor fusion genes. Hypertension 16: 301-307
90. Furchgott RF, Zawadzki JV (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373-376
91. Palmer RM, Ferrige AG, Moncada S (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524-526
92. Murad F, Mittal CK, Arnold WP, Katsuki S, Kimura H (1978) Guanylate activation by azide, nitro compounds, nitric oxide, and hydroxyl radical and inhibition by hemoglobin and myoglobin. Adv Cyclic Nucleotide Res 9: 145-158
93. Collins P, Griffith TM, Henderson AH, Lewis MJ (1978) Endothelium-derived relaxing factor alters calcium fluxes in rabbit aorta: a cyclic guanosine monophosphate-mediated effect. J Physiol (Lond) 381: 427-437
94. Konishi M, Su C (1983) Role of endothelium in dilator responses of spontaneously hypertensive rat arteries. Hypertension 5: 881-886
95. Lockette W, Otsuka Y, Carretero OA (1986) The loss of endothelium-dependent vascular relaxation in hypertension. Hypertension 8 (Suppl II): 61-66
96. Luscher TF, Raij L, Vanhoutte PM (1987) Endothelium-dependent responses in normotensive and hypertensive Dahl rats. Hypertension 9: 157-163
97. Luscher TF (1990) The endothelium. Target and promoter of hypertension? Hypertension 15: 482-485
98. Huang PL, Huang Z, Mashimo H, Bloch YD, Moskowitz MA, Bevan JA, Fishman MC (1995) Hypertension in mice lacking the gene for endothelial nitric o2dde synthase. Nature 377: 239-242
99. Luscher TF, Boulanger CM, Yang Z, Noll G, Dohi Y (1993) Interactions between endothelium-derived relaxing and contracting factors in health and cardiovascular disease. Circulation 87 (Suppl V) V36-V44
100. Calver AL, Collier J, Moncada S, Vallance P (1992) Effect of local intra-arterial NG-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal. J Hypertens 10: 1025-1031
101. Cockcroft JR, Chowienczyk PJ, Benjamin N, Ritter JM (1994) Preserved endothelium-dependent vasodilation in patients with essential hypertension. N Engl J Med 330: 1036-1040
102. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE (1990) Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 323: 22-27
103. Linder L, Kiowski W, Buhler FR, Luscher TF (1990) Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Blunted response in essential hypertension. Circulation 81: 1762-1767
104. Taddei S, Virdis A, Mattei P, Salvetti A (1993) Vasodilation to acetylcholine in primary and secondary forms of human hypertension. Hypertension 21:929-933
105. Shultz PJ, Tolins JP (1993) Adaptation to increased dietary salt intake in the rat: Role of endogenous nitric oxide. J Clin Invest 91: 1993-1997
106. Deng X, Welch WJ, Wilcox CS (1994) Renal vasoconstriction during inhibition of NO synthase: effects of dietary salt. Kidney Int 46:639-646
107. Takenaka T, Forster H, De Micheli A, Epstein M (1992) Impaired myogenic responsiveness of renal microvessels in Dahl salt-sensitive rats. Circ Res 71: 471-480
108. Coyle P (1988) High NaCl predisposes Dahl rats to cerebral infarction after middle cerebral artery occlusion. Hypertension 12: 96-101
109. Boegehold MA (1995) Flow-dependent arteriolar dilation in normotensive rats fed low-or high-salt diets. Am J Physiol 269: H1407-H1414
110. Hayakawa H, Raij L (1997) The link among nitric oxide synthase activity, endothelial function, and aortic and ventricular hypertrophy in hypertension. Hypertension 29 (part 2): 235-241
111. Deng AY, Rapp JP (1995) Locus for the inducible, but not a constitutive, nitric oxide synthase cosegregates with blood pressure in the Dahl salt-sensitive rat. J Clin Invest 95: 2170-2177
112. Chen PY, Sanders PW (1991) L-arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats. J Clin Invest 88: 1559-1567
113. Panza JA, Casino PR, Badar DM, Quyyumi AA (1993) Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension. Circulation 87: 1475-1481
114. Campese VM, Tawadrous M, Bigazzi R, Bianchi S, Mann AS, Oparil S, Raij L (1996) Salt intake nd plasma atrial natriuretic peptide and nitric oxide in hypertension. Hypertension 28: 335-340
115. Martin W, Furchgott RF, Villani GM, Jothianandan D (1986) Depression of contractile responses in rat aorta by spontaneously released endothelium-derived relaxing factor. J Pharmacol Exp Ther 237: 529-538
116. Vargas HM, Ignarro LJ, Chaudhuri G (1990) Physiological release of nitric oxide is dependent on the level of vascular tone. Eur J Pharmacol 190: 393-397
117. Adeagbo ASO, Tabrizchi R, Triggle CR (1994) The effects of perfusion rate and NG-nitro-L-arginine methyl ester on cirazoline-and KCl-induced responses in the perfused mesenteric arterial bed of rats. Br J Pharmacol 111: 13-20
118. Miyoshi A, Suzuki H, Fujiwara M, Masai M, Iwasaki T (1997) Impairment of endothelial function in salt-sensitive hypertension in humans. Am J Hypertens 10: 1083-1090
119. Grim CE, Robinson M (1996) Blood pressure variation in blacks: genetic factors. Semin Nephrol 16: 83-93
120. Lifton RP, Dluhy RG, Powers M, et al (1992) A chimeric 11β-hydroxylase aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 355: 262-265.
121. Votero-Velez M, Curtis JJ, Warnock DG (1994) Liddle's syndrome revisited. A disorder of sodium reabsorption in the distal tubule. N Engl J Med 330: 178-181
122. Mune T, Rogerson FM, Nikkila H, Agarwal AK, White PC (1995) Human hypertension caused by mutation in the kidney isozyme of the 11β-hydroxysteroid dehydrogenase. Nat Genet 10: 393-399
123. Munroe PB, Strautnieks SS, Farrall M, Daniel HI, Lawson M, DeFreitas P, Fogarty P, Gardiner RM, Caulfield M (1998) Absence of linkage of the epithelial sodium channel in hypertension in black Caribbeans. Am J Hypertens 11: 942-945
124. Weinberger MH, Miller JZ, Grim CE, Luft FC, Fineberg NS, Christian JC (1987) Sodium sensitivity and resistance of blood pressure are associated with different haptoglobin phenotypes. Hypertension 10: 443-446
125. Junemaitre X, Soubrier F, Kotelevtsen YV, Linfton RP, Williams CS, Charru A, Hunt SC, Hopkins PN, Williams RR, Lalovel JM, Corvol P (1992) Molecular basis of human hypertension: Role of angiotensinogen. Cell 71: 169-180
126. Cooper RS, Rotimi C, Obunbiyi O, Forrester T, Anderson N, Wand R (1995) Polymorphism of the RAS genes among African, Caribbean and US Blacks. Hypertension 26: 574A
127. Hiraga H, Oshima T, Watanabe M, Ishida M, Ishida T, Shingu T, Kambe M, Matsuura H, Kajiyawa G (1996) Angiotensin I converting enzyme gene polymorphism and salt sensitivity in essential hypertension. Hypertension 27: 569-572
128. Svetkey LP, Chen YT, McKeown SP, Preis L, Wilson AF (1997) Preliminary evidence of linkage of salt sensitivity in black Americans at the β2-adrenergic receptor locus. Hypertension 29: 918-922
129. Lockette W, Ghosh S, Farrow S, Mackenzie S, Baker S, Miles P, Schorr KA (1995) Alpha 2-adrenergic receptor gene polymorphism and hypertension in blacks. Am J Hypertension 8: 390-394
130. + antiporter as a candidate gene in human essential hypertension. Hypertension 17: 8-14
131. Perusse L, Deriaz O, Dionne FT, Bouchard C (1994) Association and linkage analyses of the alpha and beta genes of the sodium-potassium ATPase with age-related changes in blood pressure. Am J Hum Genet 55: 199A
132. Casari G, Barlassina C, Cusi D, Zagato L, Muirhead R, Righetti M, Nembri P, Amar K, Gatti M, Macciardi F, Binelli G, Bianchi G (1995) Association of the a-adducin locus with essential hypertension. Hypertension 25: 320-326
133. Cusi D, Barlassina C, Azzani T, Cesari G, Citterio L, Devoto M, Glorioso N, Lauzani C, Manunta P, Righetti M, Riviera R, Stella P, Troffa C, Zagato L, Bianchi G (1997) Polymorphism of α-adducin and salt sensitivity in patients with essential hypertension. Lancet 349: 1353-1357
134. Siffert W, Rosskopf D, Siffert G, Busch S, Moritz A, et al (1998) Association of a human G-protein β3 subunit variant with hypertension. Nat Genet 18: 45-48
135. Rutledge DR, Sun Y, Ross EA (1995) Polymorphism within the atrial natriuretic peptide gene in essential hypertension. J Hypertens 13: 953-955
136. Schorr U, Beige J, Ringel J, Turan S, Kreuts R, Distler A, Sharma AM (1997) Hpa II polymorphism of the atrial natriuretic peptide gene and the blood pressure responses to salt intake in normotensive men. J Hypertens 15: 715-718
137. Rubatu S, Ridker P, Stampfer M, Volpe M, Henneken CH, Lindpaintner K (1998) The gene encoding atrial natriuretic peptide and the risk of stroke in humans. Council High BP 4 (A).
138. Raij L, Azar S, Keane WF (1985) Role of hypertension in progressive glomerular immune injury. Hypertension 7: 398-404
139. + intake and early hypertension in Dahl rats. Jpn Heart J 20 (Suppl 1): 138-140
140. Bigazzi R, Bianchi S, Baldari D, Sgherri G, Baldari G, Campese VM (1994) Microalbuminuria in salt-sensitive patients: A marker for renal and cardiovascular risk factors. Hypertension 23: 195-199
141. Nesovic M, Stojanovic M, Nesovic MM, Ciric J, Zarkovic M (1996) Microalbuminuria is associated with salt sensitivity in hypertension. J Hum Hypertens 10: 573-576
142. Ruilope LM, Campo C, Rodriguez-Artalejo F, Lahera V, Garcia Robles R, Rodicio JL (1996) Blood pressure and renal function: therapeutic implications. J Hypertens 14: 1259-1263
143. Schmieder RE, Messerli FH, Garavagha GE, Nunez BD (1988) Dietary salt intake. A determinant of cardiac involvement in essential hypertension. Circulation 78: 951-956
144. Harmsen E, Leenen FH (1992) Dietary sodium induced cardiac hypertrophy. Can J Physiol Pharmacol 70: 580-586
145. Heimann JC, Drumond S, Alves ATR, Barbato AJ, Dichtchekenian V, Marcondes M (1991) Left ventricular hypertrophy is more marked in salt-sensitive than in salt-resistant hypertensive patients. J Cardiovasc Pharmacol 17(Suppl 2): S122-S124
146. Coca A, De la Sierra A (1997) Salt sensitivity and left ventricular hypertrophy. In: Zanchetti et al (Eds) Hypertension and the Heart. Plenum Press, New York, pp. 91-101
147. Bigazzi R, Bianchi S, Baldari G, Campese VM (1996) Clustering of cardiovascular risk factors in salt-sensitive patients with essential hypertension: Role of insulin. Am J Hypertens 9: 24-32